Thakur M L, McKenney S L, Park C H
J Nucl Med. 1985 May;26(5):510-7.
The need for a gamma-emitting radioactive agent that will label platelets in plasma efficiently by a procedure that can be used uniformly in each laboratory is well recognized. A water soluble sodium salt of 2-Mercaptopyridine-N-oxide (Merc) was evaluated that quantitatively chelated 111ln at a pH range of 0.7 to 7.4, and allowed greater than 80% incorporation of 111ln in platelets in plasma. This was dependent on pH, Merc concentration, and platelet concentration. Platelets were labeled using either preformed [111ln]Merc or incubating platelets with 2.5 micrograms dry Merc first and then with 111ln. The latter method provided a simple kit procedure that labeled platelets with negligible alteration of in vitro aggregability. In dogs, labeled platelets had normal survival (7.5 days), 66 +/- 6.6% recovery, detected vascular thrombi (thrombi/blood = 59.4), and pulmonary emboli (PE/blood = 46.2) by scintigraphy. In the kit procedure, the use of Merc compared favorably to that of oxine and tropolone.
人们已经充分认识到需要一种能通过各实验室均可统一使用的方法有效标记血浆中血小板的发射γ射线的放射性试剂。对2-巯基吡啶-N-氧化物(Merc)的水溶性钠盐进行了评估,它在0.7至7.4的pH范围内能定量螯合铟-111,并使血浆中血小板对铟-111的摄取率超过80%。这取决于pH值、Merc浓度和血小板浓度。使用预先形成的[铟-111]Merc或先将血小板与2.5微克干燥的Merc孵育,然后再与铟-111孵育来标记血小板。后一种方法提供了一种简单的试剂盒程序,标记的血小板在体外聚集性的改变可忽略不计。在犬类中,标记的血小板存活正常(7.5天),回收率为66±6.6%,通过闪烁扫描可检测到血管血栓(血栓/血液 = 59.4)和肺栓塞(肺栓塞/血液 = 46.2)。在试剂盒程序中,Merc的使用效果优于8-羟基喹啉和托酚酮。